SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Needham Maintains Buy on Globus Medical, Lowers Price Target to $60

Needham maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $63 to $60.

Benzinga · 05/08/2020 10:56

Needham maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $63 to $60.